BSH18-PO-150: Complement inhibition with Eculizumab affects fibrinogen levels and clot Structure in patients with Paroxysmal Nocturnal Haemoglobinuria

Macrae, F, Bowman, P, Linton, E et al. (9 more authors) (2018) BSH18-PO-150: Complement inhibition with Eculizumab affects fibrinogen levels and clot Structure in patients with Paroxysmal Nocturnal Haemoglobinuria. In: British Journal of Haematology. 58th Annual Scientific Meeting of the British Society for Haematology, 16-18 Apr 2018, Liverpool, UK. Wiley, p. 130. ISSN: 0007-1048 EISSN: 1365-2141

Metadata

Item Type:	Proceedings Paper
Authors/Creators:	Macrae, F Bowman, P Linton, E Peacock-Young, B Clarke, D Newton, D https://orcid.org/0000-0002-0214-1486 McKinley, C https://orcid.org/0000-0003-4006-8846 Riley, K Copeland, N Arnold, L Ariens, R https://orcid.org/0000-0002-6310-5745 Hill, A
Keywords:	clotting; eculizumab; fibrinogen; paroxysmal nocturnal haemoglobinuria; thrombosis
Dates:	Published (online): 16 April 2018 Published: April 2018
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)
Funding Information:	Funder Grant number British Heart Foundation PG/16/60/32292
Depositing User:	Symplectic Publications
Date Deposited:	18 Feb 2020 15:58
Last Modified:	18 Feb 2020 15:58
Status:	Published
Publisher:	Wiley
Identification Number:	10.1111/bjh.15226
Related URLs:	Author
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:157199

CORE (COnnecting REpositories)

BSH18-PO-150: Complement inhibition with Eculizumab affects fibrinogen levels and clot Structure in patients with Paroxysmal Nocturnal Haemoglobinuria

Metadata

Download not available

Export

Statistics